Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study

Bin Zhou,1,2 Jiachen Gui,2,3 Tao Wang,2,4 Zhimin Li,2 Wenzhi Hu,5 Yue Zhang,2 Qiang Li2 1Graduate School, Hebei North University, Zhangjiakou, People’s Republic of China; 2Department of Dermatology, Air Force Medical Center, PLA, Beijing, People’s Republic of China; 3Air Force Medical University, Xi...

Full description

Bibliographic Details
Published in:	Clinical, Cosmetic and Investigational Dermatology
Main Authors:	Zhou B, Gui J, Wang T, Li Z, Hu W, Zhang Y, Li Q
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-12-01
Subjects:	efficacy safety assessment autoimmune disease re-pigmentation.
Online Access:	https://www.dovepress.com/combination-therapy-with-baricitinib-and-narrowband-ultraviolet-b-for--peer-reviewed-fulltext-article-CCID

Similar Items

Long-term Durability of Narrowband Ultraviolet B-induced Repigmentation in Non-segmental Vitiligo: A Retrospective Study
by: Riad Kassem, et al.
Published: (2025-09-01)

Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001)
by: Lisa Liu, BS, et al.
Published: (2023-09-01)

Effectiveness of Narrowband Ultraviolet on Vitiligo: A Systematic Review
by: Ana Luisa Tenani Pereira da Costa, et al.
Published: (2024-12-01)

The efficacy of narrowband ultraviolet B phototherapy combination with tofacitinib in the treatment of vitiligo: a randomized controlled trial
by: Xiaoyan Guo, et al.
Published: (2025-12-01)

Peningkatan Jumlah Protein S100 pada Vitiligo setelah Terapi Narrowband-Ultraviolet B
by: Putri Hendria Wardhani, et al.
Published: (2018-09-01)

Clinico-Epidemiological Profile of Vitiligo Patients Receiving Narrowband Ultraviolet-B (NB-UVB) Treatment
by: Anasya Putri Ramadhina, et al.
Published: (2023-03-01)

Baricitinib is potentially effective in the treatment of refractory livedoid vasculopathy
by: Yuyang Han, et al.
Published: (2022-10-01)

Vitiligo Treated with Combined Piperine-Based Topical Treatment and Narrowband Ultraviolet B Therapy: Follow-Up with Reflectance Confocal Microscopy
by: Cristina Bertoli, et al.
Published: (2024-02-01)

Evaluation of the clinical and sociodemographic features of patients with vitiligo from the central region of Romania
by: Laszlo Fekete, et al.
Published: (2025-03-01)

Vitiligo: Prevalence, clinical patterns, and efficacy of narrow band ultraviolet B phototherapy
by: Yoganand Jagannath Phulari, et al.
Published: (2023-01-01)

Efficacy and safety of baricitinib for the treatment of hospitalized adults with COVID-19: a systematic review and meta-analysis
by: Jing Sun, et al.
Published: (2023-11-01)

Knowledge and attitudes towards vitiligo in egyptian and palestinian communities: a cross-sectional study
by: Aya Mohammed Sharkawy, et al.
Published: (2025-04-01)

Comparative efficacy and safety of targeted narrowband ultraviolet B, 308-nm excimer laser, and 308-nm excimer lamp in vitiligo: a retrospective study
by: Thamonwan Tantivithiwate, et al.
Published: (2025-12-01)

The efficacy and safety of micro-needling combined with tacrolimus <i>versus</i> tacrolimus monotherapy for vitiligo treatment: a systematic review and meta-analysis
by: Hadeel A. Maaddawi, et al.
Published: (2025-02-01)

Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy
by: Li X, et al.
Published: (2023-03-01)

Dermoscopic and Clinical Response Predictor Factors in Nonsegmental Vitiligo Treated with Narrowband Ultraviolet B Phototherapy: A Prospective Observational Study
by: Enzo Errichetti, et al.
Published: (2020-08-01)

Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro
by: Jie Dong, et al.
Published: (2022-04-01)

Narrowband Ultraviolet B (NB-UVB) Phototherapy in Psoriasis: A Retrospective Study
by: Faida Ufaira Prameswari, et al.
Published: (2022-07-01)

Vitiligo and autoimmune diseases
by: Magdalena Kutwin, et al.
Published: (2016-10-01)

Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo
by: Laura Macca, et al.
Published: (2022-09-01)

A Retrospective Comparison of Narrowband-UVB Phototherapy in Pediatric Versus Adult Vitiligo
by: Kristin A. Tissera, et al.
Published: (2025-04-01)

Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study
by: Zhongyi Xu, et al.
Published: (2025-12-01)

The role of narrowband ultraviolet B phototherapy in the treatment of refractory osteomalacia
by: João Teixeira, et al.
Published: (2024-10-01)

The effect of narrowband ultraviolet B phototherapy on serum folate level
by: Azar Shirzadian kebria, et al.
Published: (2021-03-01)

Patient-derived VIDA and dermoscopy versus sequential planimetry for assessing activity in vitiligo patients receiving narrowband ultraviolet B: a comparative longitudinal study
by: Ali F. El Eriny, et al.
Published: (2025-01-01)

A 7-Year Retrospective Study of Narrowband Ultraviolet B Phototherapy for Psoriasis in Geriatric Patients
by: Lili Legiawati, et al.
Published: (2025-03-01)

Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
by: Alvina Widhani, et al.
Published: (2023-09-01)

Comparative Evaluation of the Therapeutic Efficacy of Microneedling Alone or Microneedling Combined with Topical 5-Fluorouracil In Localized Stable Childhood Vitiligo
by: B C Ghiya, et al.
Published: (2016-01-01)

Leptin deficiency in CD8+ T cells ameliorates non-segmental vitiligo by reducing interferon-γ and Granzyme B
by: Meiyu Wu, et al.
Published: (2023-05-01)

Psychosis in Three Patients with Vitiligo
by: A KHeradmand, et al.
Published: (2009-07-01)

The effect of narrowband ultraviolet B on tissue level of interleukin-15 and interleukin-15 receptor alpha subunit in active nonsegmental vitiligo cases: an interventional cohort study
by: Randa Youssef, et al.
Published: (2024-05-01)

Dysregulated Intracellular Signaling in the Pathogenesis of Vitiligo: An Update on Emerging Therapeutic Strategies
by: Ramona Marrapodi, et al.
Published: (2025-09-01)

JAK Inhibitors in Down Syndrome: Alopecia Areata Resolution and Vitiligo Improvement with Baricitinib
by: Federica Li Pomi, et al.
Published: (2025-09-01)

Short-term (24 weeks) treatment efficacy and safety of ruxolitinib cream in participants with vitiligo: a systematic review and meta-analysis
by: Yuan Yuan, et al.
Published: (2024-10-01)

A Clinical Image of Basal Cell Carcinoma in Universal Vitiligo
by: Asharbh Raman, et al.
Published: (2025-05-01)

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis
by: Khaled Ezzedine, et al.
Published: (2023-09-01)

Assessing the impact of anti-nuclear antibodies on the severity and types of vitiligo: a retrospective clinical investigation
by: Rasha Aoun, et al.
Published: (2025-10-01)

The first childhood case with coexisting Hashimoto thyroiditis, vitiligo and autoimmune hepatitis
by: Melikşah Keskin, et al.
Published: (2016-08-01)

Comparison of the Excimer Lamp vs. Narrowband Ultraviolet (Nb-Uvb) Lamp or 308 nm Excimer Laser in Vitiligo Repigmentation: A Systematic Review
by: Nathalia Bakes Teodoro, et al.
Published: (2025-07-01)

Pigmented purpuric dermatosis (Majocchi type) in a patient with vitiligo
by: Nattanicha Chaisrimaneepan, et al.
Published: (2024-03-01)